Lymphoma classification and the tools of our trade: an introduction to the 2012 USCAP Long Course

[1]  E. Campo.  Whole genome profiling and other high throughput technologies in lymphoid neoplasms—current contributions and future hopes , 2013, Modern Pathology.

[2]  N. Harris,et al.  MYD88 L265P somatic mutation in Waldenström's macroglobulinemia. , 2012, The New England journal of medicine.

[3]  S. Swerdlow,et al.  THYROID CARCINOMA-ASSOCIATED GENETIC MUTATIONS ALSO OCCUR IN THYROID LYMPHOMAS , 2012, Modern Pathology.

[4]  A. Dobrovic,et al.  Detection of BRAF mutations in patients with hairy cell leukemia and related lymphoproliferative disorders , 2012, Haematologica.

[5]  K. Kok,et al.  CGH arrays compared for DNA isolated from formalin‐fixed, paraffin‐embedded material , 2012, Genes, chromosomes & cancer.

[6]  R. Warnke,et al.  In situ mantle cell lymphoma: clinical implications of an incidental finding with indolent clinical behavior , 2012, Haematologica.

[7]  R. Foà,et al.  Simple genetic diagnosis of hairy cell leukemia by sensitive detection of the BRAF-V600E mutation. , 2012, Blood.

[8]  Mario Cazzola,et al.  The BRAF V600E mutation in hairy cell leukemia and other mature B-cell neoplasms. , 2012, Blood.

[9]  A. Sivachenko,et al.  SF3B1 and other novel cancer genes in chronic lymphocytic leukemia. , 2011, The New England journal of medicine.

[10]  Mark Gerstein,et al.  Genome-Wide Mapping of Copy Number Variation in Humans: Comparative Analysis of High Resolution Array Platforms , 2011, PloS one.

[11]  H. Greisman,et al.  Rapid high-resolution mapping of balanced chromosomal rearrangements on tiling CGH arrays. , 2011, The Journal of molecular diagnostics : JMD.

[12]  E. Jaffe,et al.  Follicular lymphoma in situ: clinical implications and comparisons with partial involvement by follicular lymphoma. , 2011, Blood.

[13]  Raul Rabadan,et al.  Analysis of the Coding Genome of Diffuse Large B-Cell Lymphoma , 2011, Nature Genetics.

[14]  Juliane C. Dohm,et al.  Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia , 2011, Nature.

[15]  L. Pasqualucci,et al.  Analysis of the chronic lymphocytic leukemia coding genome: role of NOTCH1 mutational activation , 2011, The Journal of experimental medicine.

[16]  S. Pileri,et al.  BRAF mutations in hairy-cell leukemia. , 2011, The New England journal of medicine.

[17]  E. Jaffe,et al.  Clonally related Histiocytic/dendritic cell sarcoma and chronic lymphocytic leukemia/small lymphocytic lymphoma: A study of 7 cases , 2011, Modern Pathology.

[18]  R. Hartsock,et al.  Classifications of lymphoma; reflections of time and technology , 2011, Virchows Archiv.

[19]  Joseph M. Connors,et al.  Oncogenically active MYD88 mutations in human lymphoma , 2011, Nature.

[20]  U. Surti,et al.  Clinicopathologic Features of Histiocytic Lesions following ALL, with a Review of the Literature , 2010, Pediatric and developmental pathology : the official journal of the Society for Pediatric Pathology and the Paediatric Pathology Society.

[21]  S. Swerdlow,et al.  Best practices in contemporary diagnostic immunohistochemistry: panel approach to hematolymphoid proliferations. , 2009, Archives of pathology & laboratory medicine.

[22]  D. Arber,et al.  High Frequency of Clonal Immunoglobulin Receptor Gene Rearrangements in Sporadic Histiocytic/Dendritic Cell Sarcomas , 2009, The American journal of surgical pathology.

[23]  Anju Thomas,et al.  Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificity. , 2009, American journal of clinical pathology.

[24]  N. Harris,et al.  Classification of lymphoid neoplasms: the microscope as a tool for disease discovery. , 2008, Blood.

[25]  U. Surti,et al.  Fluorescence Immunophenotypic and Interphase Cytogenetic Characterization of Nodal Lymphoplasmacytic Lymphoma , 2008, The American journal of surgical pathology.

[26]  R. Warnke,et al.  Clonally related follicular lymphomas and histiocytic/dendritic cell sarcomas: evidence for transdifferentiation of the follicular lymphoma clone. , 2008, Blood.

[27]  S. Serrano,et al.  FISH is better than BIOMED-2 PCR to detect IgH/BCL2 translocation in follicular lymphoma at diagnosis using paraffin-embedded tissue sections. , 2008, Leukemia research.

[28]  T. Molina,et al.  Polymerase chain reaction-based clonality testing in tissue samples with reactive lymphoproliferations: usefulness and pitfalls. A report of the BIOMED-2 Concerted Action BMH4-CT98-3936 , 2007, Leukemia.

[29]  T. Molina,et al.  Significantly improved PCR-based clonality testing in B-cell malignancies by use of multiple immunoglobulin gene targets. Report of the BIOMED-2 Concerted Action BHM4-CT98-3936 , 2007, Leukemia.

[30]  T. Molina,et al.  Powerful strategy for polymerase chain reaction-based clonality assessment in T-cell malignancies Report of the BIOMED-2 Concerted Action BHM4 CT98-3936 , 2007, Leukemia.

[31]  S. Swerdlow,et al.  Abnormal patterns of antigenic expression in follicular lymphoma: a flow cytometric study. , 2005, American journal of clinical pathology.

[32]  K. Lennert.  Obituary — Professor Dr. Robert J. Lukes , 1995, Annals of Hematology.

[33]  J. Cook.  Paraffin Section Interphase Fluorescence In Situ Hybridization in the Diagnosis and Classification of Non-Hodgkin Lymphomas , 2004, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[34]  S. Swerdlow,et al.  Utility of routine classical cytogenetic studies in the evaluation of suspected lymphomas: results of 279 consecutive lymph node/extranodal tissue biopsies. , 2004, American journal of clinical pathology.

[35]  R. Braziel,et al.  Prominent clonal B-cell populations identified by flow cytometry in histologically reactive lymphoid proliferations. , 2004, American journal of clinical pathology.

[36]  E. Jaffe.  Pathology and Genetics: Tumours of Haematopoietic and Lymphoid Tissues , 2003 .

[37]  R. Siebert,et al.  Interphase cytogenetics of hematological neoplasms under the perspective of the novel WHO classification. , 2003, Anticancer research.

[38]  A. Norton,et al.  Classification of non-Hodgkin's lymphomas. , 1996, Bailliere's clinical haematology.

[39]  H Stein,et al.  A revised European-American classification of lymphoid neoplasms: a proposal from the International Lymphoma Study Group. , 1994, Blood.

[40]  K. Lennert,et al.  Updated Kiel classification for lymphomas , 1989, The Journal of pathology.

[41]  P. Isaacson,et al.  Extranodal malignant lymphoma arising from mucosa‐associated lymphoid tissue , 1984, Cancer.

[42]  K. Lennert,et al.  Concordance of the Kiel and Lukes‐Collins classifications of non‐Hodgkin's lymphomas , 1983, Histopathology.

[43]  National Cancer Institute sponsored study of classifications of non-Hodgkin's lymphomas: summary and description of a working formulation for clinical usage. The Non-Hodgkin's Lymphoma Pathologic Classification Project. , 1982, Cancer.

[44]  Lukes Rj.  The immunologic approach to the pathology of malignant lymphomas. , 1979 .

[45]  R. Lukes.  The immunologic approach to the pathology of malignant lymphomas. , 1979, American journal of clinical pathology.

[46]  I. Katayama,et al.  Letter: Classification of non-Hodgkin's lymphomas. , 1974, Lancet.

[47]  R. Lukes,et al.  Immunologic characterization of human malignant lymphomas , 1974, Cancer.

[48]  H. Kay.  CLASSIFICATION OF NON-HODGKIN'S LYMPHOMAS , 1974 .

[49]  K. Lennert,et al.  Classification of Non-Hodgkin’s Lymphomas , 1974 .

[50]  R. Dorfman.  CLASSIFICATION OF NON-HODGKIN'S LYMPHOMAS , 1974 .

[51]  H. Rappaport,et al.  Tumors of the hematopoietic system , 1966 .

[52]  Henry Rappaport,et al.  Follicular lymphoma. A re‐evaluation of its position in the scheme of malignant lymphoma based on a survey of 253 cases , 1956 .

[53]  E. Kendall.  The adrenal cortex and rheumatoid arthritis. , 1951, British medical journal.